Skip to Content

Join the 'Spiriva Respimat' group to help and get support from people like you.

Spiriva Respimat News

Long-Acting Inhaler May Help in Early Stage COPD, Too

Posted 6 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 6, 2017 – The inhaler medication Spiriva (tiotropium bromide) may help slow the progression of COPD if given in the early stages of the disease, a new study suggests. Researchers found that the drug helped patients preserve more lung function over two years. It also cut down on symptom flare-ups and boosted patients' quality of life, on average. All of the study patients were in the early stages of chronic obstructive pulmonary disease, or COPD – a group of serious lung conditions that include emphysema and chronic bronchitis. Experts said the study, funded by Spiriva maker Boehringer Ingelheim, could help change the way early COPD is managed. Until now, nothing has been shown to slow the progression of early COPD – other than smoking cessation, said Dr. Louis DePalo, a lung disease specialist who wasn't involved in the study. "Quitting smoking is the one thing ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Smoking, Smoking Cessation, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Chronic Obstructive Pulmonary Disease, Acute, Spiriva HandiHaler, Tiotropium, Stiolto Respimat, Alpha-1 Proteinase Inhibitor Deficiency, Spiriva Respimat, Olodaterol/tiotropium

Obesity May Raise Girls' Risk of Asthma, Allergies

Posted 6 Mar 2017 by Drugs.com

MONDAY, March 6, 2017 – Obese girls may face a significantly higher risk for developing allergies, a new study suggests. But the researchers found the opposite was true for obese boys: They may actually face a slightly diminished risk for asthma, food allergies and eczema when compared to normal-weight boys. "We found a direct increase in the number of atopic [allergic] diseases associated with obesity in urban female children and teenagers, but not in males," said study co-author Dr. Sairaman Nagarajan. He's a resident physician in the department of pediatrics at SUNY Downstate Medical Center in New York City. "These results were highly significant, even after adjusting for the effects of age and race," he said. Nagarajan and his colleagues were scheduled to present their findings Monday at the annual meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), in Atlanta. ... Read more

Related support groups: Obesity, Asthma, Weight Loss, Asthma - Maintenance, Spiriva, Fluticasone, Qvar, Budesonide, Asthma - Acute, Flovent, Entocort, Ipratropium, Mometasone, Entocort EC, Atrovent, Spiriva HandiHaler, Tiotropium, Beclomethasone, Uceris, Alvesco

FDA Expands Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children

Posted 27 Feb 2017 by Drugs.com

RIDGEFIELD, Conn., February 16, 2017 - Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat for the long-term, once-daily maintenance treatment of asthma in people age 6 and older. Spiriva Respimat is not a treatment for sudden asthma symptoms. The FDA approved the Supplemental New Drug Application (sNDA) under a priority review designation, and the FDA also granted pediatric exclusivity to Spiriva Respimat in light of the clinical trials conducted by Boehringer Ingelheim. Spiriva Respimat is steroid-free and works differently from other treatment options to open airways to help people breathe better. In its comprehensive clinical trial program, Spiriva Respimat demonstrated proven efficacy and safety for patients age 6 and older. “It is important for healthcare providers to identify and treat patients w ... Read more

Related support groups: Asthma, Asthma - Maintenance, Spiriva, Spiriva HandiHaler, Tiotropium, Spiriva Respimat

Mice May Be Key to Kids' Asthma Attacks at School

Posted 2 Dec 2016 by Drugs.com

FRIDAY, Dec. 2, 2016 – Research investigating schoolchildren's asthma attacks has pointed to a tiny foe: mice. Allergens from the rodents can infiltrate the air, the study found, and may be a major cause of asthma attacks in the school environment. It's known that many different allergy triggers – from dust mites to mold to pet dander – can fuel children's asthma symptoms. But most research has focused on the triggers in kids' homes. "In this study, we've identified the school as an important factor, too," said researcher Dr. Wanda Phipatanakul, an allergy specialist at Boston Children's Hospital. That said, she stressed, the findings do not actually prove that schools' rodent problems were the cause of kids' symptoms. The next step, Phipatanakul said, is a study where schools will get air purifiers and "integrated pest management," to see if that improves students' respiratory ... Read more

Related support groups: Asthma, Symbicort, Asthma - Maintenance, Spiriva, Advair Diskus, Fluticasone, Advair HFA, Qvar, Budesonide, Asthma - Acute, Flovent, Breo Ellipta, Entocort, Dulera, Combivent, Ipratropium, Bronchial, Mometasone, Entocort EC, Atrovent

COPD Deaths Down for Most Americans: CDC

Posted 8 Sep 2016 by Drugs.com

THURSDAY, Sept. 8, 2016 – Fewer Americans are dying from chronic obstructive pulmonary disease (COPD), but not black women and the middle-aged, a new government report shows. Between 2000 and 2014, there was a 12 percent overall drop in deaths from the progressive lung disease, according to the U.S. Centers for Disease Control and Prevention. Report co-author Hanyu Ni said the figures aren't unexpected, noting that "the declines in the COPD-related mortality are consistent with declines in the prevalence of current smoking for men and women in the United States." But, Ni added, the study only quantified death rate trends, and didn't look at the reasons behind those trends. Ni is an associate director for science with the CDC's division of vital statistics at the U.S. National Center for Health Statistics. Dr. David Mannino, who's with the University of Kentucky's College of Public ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Albuterol, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Ventolin, Fluticasone, Qvar, Ribavirin, Budesonide, Flovent, Epinephrine, Entocort, Xopenex, ProAir HFA, Ipratropium, Tobramycin, Entocort EC, EpiPen, Mometasone, Chronic Obstructive Pulmonary Disease, Acute

Secondhand Smoke May Double Risk of Hospitalization for Kids With Asthma

Posted 24 Sep 2015 by Drugs.com

THURSDAY, Sept. 24, 2015 – Exposure to secondhand smoke puts children with asthma at nearly double the risk of winding up in the hospital, a new analysis reveals. For these kids, secondhand smoke can worsen symptoms and make their condition more difficult to control. So parents need to be aware of these additional risks, the researchers warned. "Previous studies have linked secondhand smoke exposure with increased asthma prevalence, poorer asthma control and increased symptoms," lead study author Zhen Wang, from the Mayo Clinic in Rochester, Minn., said in an American College of Allergy, Asthma and Immunology news release. "We wanted to quantify the strength of the association, and to show just how much greater the risk is of hospitalization for kids with asthma who are exposed to secondhand smoke in the home," Wang added. One expert said the findings make sense. "Having treated ... Read more

Related support groups: Asthma, Smoking, Symbicort, Asthma - Maintenance, Spiriva, Advair Diskus, Fluticasone, Advair HFA, Qvar, Budesonide, Asthma - Acute, Flovent, Breo Ellipta, Entocort, Dulera, Combivent, Ipratropium, Mometasone, Entocort EC, Atrovent

FDA Approves Spiriva Respimat (tiotropium) for Maintenance Treatment of Asthma in Adults and Adolescents

Posted 17 Sep 2015 by Drugs.com

RIDGEFIELD, Conn., September 16, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Spiriva Respimat for the long-term, once-daily, prescription maintenance treatment of asthma in people ages 12 and older. Spiriva Respimat is not a treatment for sudden asthma symptoms. Asthma, which affects more than 22 million people in the U.S., can cause a patient’s airways to become inflamed and tighten, making it hard to breathe. Despite currently available treatments, many patients continue to experience asthma symptoms, which can have a negative impact on their ability to perform daily activities. One survey found 55 percent of people with asthma taking at least one treatment still experienced symptoms. The approval of Spiriva Respimat establishes a new class of asthma medication known as long-acting muscarinic antagonists ... Read more

Related support groups: Asthma, Asthma - Maintenance, Spiriva, Tiotropium, Spiriva Respimat

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease, Maintenance, Asthma - Maintenance

Spiriva Respimat Patient Information at Drugs.com